COM:JANUXRX
Janux Therapeutics
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
januxrx.comcrunchbase
janux-therapeuticslinkedin
janux-therapeuticsfounding date
Jan 01, 2017ipo date
Jun 11, 2021
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast ...Show More